Log in to save to my catalogue

Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell l...

Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell l...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8cc4aa9103de41798ff08221aa4e3b65

Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study

About this item

Full title

Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study

Publisher

London: BioMed Central Ltd

Journal title

Radiation oncology (London, England), 2023-08, Vol.18 (1), p.1-140, Article 140

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background In this study, we evaluated the efficacy and toxicity of stereotactic body radiotherapy (SBRT) as replacement strategy of conventionally fractionated radiation therapy in stage III non-small cell lung cancer (NSCLC) patients unfit for concurrent chemoradiation therapy (CRT). Methods We analyzed the clinical outcomes in patients with unre...

Alternative Titles

Full title

Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8cc4aa9103de41798ff08221aa4e3b65

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8cc4aa9103de41798ff08221aa4e3b65

Other Identifiers

ISSN

1748-717X

E-ISSN

1748-717X

DOI

10.1186/s13014-023-02333-1

How to access this item